☰

Gagani Athauda, MD - Publications

Affiliations: 
2003-2005 Urologic Oncology Branch National Cancer Institue-NIH 
 2006- Cellular Biology and Pharmacology Herbert Wertheim College of Medicine, Florida International University 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 McNeil BK, Sorbellini M, Grubb RL, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal PK, Coleman J, Getzenberg RH, Netto GJ, Shih J, Linehan WM, et al. Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder. Journal of Translational Medicine. 12: 199. PMID 25335552 DOI: 10.1186/1479-5876-12-199  0.713
2012 Athauda G, Cecchi F, Ito T, Giubellino A, Rabe D, Raffensperger K, Lee Y, Bottaro D. HGF (hepatocyte growth factor (hepapoietin A; scatter factor)) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/46082  0.533
2011 Sorbellini M, McNeil B, Cohen B, Athauda G, Giubellino A, Coleman J, Netto GJ, Getzenberg RH, Linehan W, Bottaro DP. Urinary Met level as a novel biomarker for urothelial carcinoma of the bladder. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 257. PMID 27968502 DOI: 10.1200/Jco.2011.29.7_Suppl.257  0.667
2009 Peach ML, Tan N, Choyke SJ, Giubellino A, Athauda G, Burke TR, Nicklaus MC, Bottaro DP. Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. Journal of Medicinal Chemistry. 52: 943-51. PMID 19199650 DOI: 10.1021/Jm800791F  0.616
2009 Monje PV, Rendon S, Athauda G, Bates M, Wood PM, Bunge MB. Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation. Glia. 57: 947-61. PMID 19053056 DOI: 10.1002/Glia.20819  0.345
2008 Giubellino A, Shi ZD, Jenkins LM, Worthy KM, Bindu LK, Athauda G, Peruzzi B, Fisher RJ, Appella E, Burke TR, Bottaro DP. Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist. Journal of Medicinal Chemistry. 51: 7459-68. PMID 18989951 DOI: 10.1021/Jm800523U  0.703
2008 Monje PV, Athauda G, Wood PM. Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation. The Journal of Biological Chemistry. 283: 34087-100. PMID 18799465 DOI: 10.1074/Jbc.M802318200  0.363
2008 Athauda G, Bottaro DP. GRB2 (Growth factor receptor-bound protein 2) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/16961  0.572
2006 Peruzzi B, Athauda G, Bottaro DP. The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 14531-6. PMID 16983094 DOI: 10.1073/Pnas.0606850103  0.69
2006 Athauda G, Giubellino A, Coleman JA, Horak C, Steeg PS, Lee MJ, Trepel J, Wimberly J, Sun J, Coxon A, Burgess TL, Bottaro DP. c-Met ectodomain shedding rate correlates with malignant potential. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4154-62. PMID 16857786 DOI: 10.1158/1078-0432.Ccr-06-0250  0.712
Show low-probability matches.